Agarabi C - Search Results

1

Mycoplasma Clearance and Risk Analysis in a Model Bioprocess.

Wang J, Johnson S, Brown M, Lute S, Agarabi C, Dabrazhynetskaya A, Chizhikov V, Brorson K. Wang J, et al. Among authors: agarabi c. PDA J Pharm Sci Technol. 2017 Mar-Apr;71(2):99-114. doi: 10.5731/pdajpst.2016.007054. Epub 2017 Jan 15. PDA J Pharm Sci Technol. 2017. PMID: 28089962

2

Quality by design: impact of formulation variables and their interactions on quality attributes of a lyophilized monoclonal antibody.

Awotwe-Otoo D, Agarabi C, Wu GK, Casey E, Read E, Lute S, Brorson KA, Khan MA, Shah RB. Awotwe-Otoo D, et al. Among authors: agarabi c. Int J Pharm. 2012 Nov 15;438(1-2):167-75. doi: 10.1016/j.ijpharm.2012.08.033. Epub 2012 Aug 25. Int J Pharm. 2012. PMID: 22944306

3

Fermentanomics informed amino acid supplementation of an antibody producing mammalian cell culture.

Read EK, Bradley SA, Smitka TA, Agarabi CD, Lute SC, Brorson KA. Read EK, et al. Among authors: agarabi cd. Biotechnol Prog. 2013 May-Jun;29(3):745-53. doi: 10.1002/btpr.1728. Epub 2013 Apr 22. Biotechnol Prog. 2013. PMID: 23606649

4

Impact of controlled ice nucleation on process performance and quality attributes of a lyophilized monoclonal antibody.

Awotwe-Otoo D, Agarabi C, Read EK, Lute S, Brorson KA, Khan MA, Shah RB. Awotwe-Otoo D, et al. Among authors: agarabi c. Int J Pharm. 2013 Jun 25;450(1-2):70-8. doi: 10.1016/j.ijpharm.2013.04.041. Epub 2013 Apr 22. Int J Pharm. 2013. PMID: 23618961

5

Bioreactor process parameter screening utilizing a Plackett-Burman design for a model monoclonal antibody.

Agarabi CD, Schiel JE, Lute SC, Chavez BK, Boyne MT 2nd, Brorson KA, Khan M, Read EK. Agarabi CD, et al. J Pharm Sci. 2015 Jun;104(6):1919-1928. doi: 10.1002/jps.24420. Epub 2015 Mar 11. J Pharm Sci. 2015. PMID: 25762022

6

Product and process understanding to relate the effect of freezing method on glycation and aggregation of lyophilized monoclonal antibody formulations.

Awotwe-Otoo D, Agarabi C, Read EK, Lute S, Brorson KA, Khan MA. Awotwe-Otoo D, et al. Among authors: agarabi c. Int J Pharm. 2015 Jul 25;490(1-2):341-50. doi: 10.1016/j.ijpharm.2015.03.056. Epub 2015 Mar 30. Int J Pharm. 2015. PMID: 25835267

7

Fermentanomics: Relating quality attributes of a monoclonal antibody to cell culture process variables and raw materials using multivariate data analysis.

Rathore AS, Kumar Singh S, Pathak M, Read EK, Brorson KA, Agarabi CD, Khan M. Rathore AS, et al. Biotechnol Prog. 2015 Nov-Dec;31(6):1586-99. doi: 10.1002/btpr.2155. Epub 2015 Aug 31. Biotechnol Prog. 2015. PMID: 26280800

8

N-Glycosylation Design and Control of Therapeutic Monoclonal Antibodies.

Sha S, Agarabi C, Brorson K, Lee DY, Yoon S. Sha S, et al. Among authors: agarabi c. Trends Biotechnol. 2016 Oct;34(10):835-846. doi: 10.1016/j.tibtech.2016.02.013. Epub 2016 Mar 22. Trends Biotechnol. 2016. PMID: 27016033 Review.

9

Improved Stability of a Model IgG3 by DoE-Based Evaluation of Buffer Formulations.

Chavez BK, Agarabi CD, Read EK, Boyne MT 2nd, Khan MA, Brorson KA. Chavez BK, et al. Biomed Res Int. 2016;2016:2074149. doi: 10.1155/2016/2074149. Epub 2016 Mar 3. Biomed Res Int. 2016. PMID: 27042659 Free PMC article.

10

Effect of amino acid supplementation on titer and glycosylation distribution in hybridoma cell cultures-Systems biology-based interpretation using genome-scale metabolic flux balance model and multivariate data analysis.

Reimonn TM, Park SY, Agarabi CD, Brorson KA, Yoon S. Reimonn TM, et al. Biotechnol Prog. 2016 Sep;32(5):1163-1173. doi: 10.1002/btpr.2335. Epub 2016 Aug 3. Biotechnol Prog. 2016. PMID: 27452371

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

45 results

Search Page

Filters